 |
 |
|
|
|
| |
|
|
 |
| |
|
|
| |
Sadra Medical is dedicated
to developing innovative new therapies for the treatment of
aortic valve disease. By developing minimally invasive alternatives
to traditional surgical valve replacement, the company seeks
to help improve patient care and make valve replacement possible
for broader range of patients. Treatment of aortic valve disease
remains a significant and growing unmet clinical need. As many
as 3 million people in U.S. have aortic valve stenosis; however,
only a small percentage of those are treated with the current
standard of care, valve replacement during open-heart surgery
using cardiopulmonary bypass. By developing a highly effective
aortic valve replacement that is designed to reduce the risks
and morbidity associated with open surgical valve replacement,
Sadra Medical seeks to provide a therapeutic option for patients
who are not being treated today. |
|
| |
|
|
|
|
|
|
|
|
